John G. Hintermeister

Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision

Cheryl A. London, Phyllis B. Malpas, Stacey L. Wood-Follis et al. · Clinical Cancer Research · 2009 · 422 citations · Full text

Medicine, Oncology, Pharmacology +15

Analysis of Factors Affecting Survival in Dogs With Aortic Body Tumors

Nicole Ehrhart, E. J. Ehrhart, Jennifer Willis et al. · Veterinary Surgery · 2002 · 82 citations

Veterinary Medicine, Veterinary Oncology, Veterinary Surgery +14

Evaluation of Intravenous Pamidronate Administration in 33 Cancer-Bearing Dogs with Primary or Secondary Bone Involvement

Timothy M. Fan, Louis‐Philippe de Lorimier, Sarah C. Charney et al. · Journal of Veterinary Internal Medicine · 2005 · 67 citations · Full text

Medicine, Veterinary Oncology, Veterinary Pharmacology +16

Evaluation of Intravenous Pamidronate Administration in 33 Cancer-Bearing Dogs with Primary or Secondary Bone Involvement

Timothy M. Fan, Louis‐Philippe de Lorimier, Sarah C. Charney et al. · Journal of Veterinary Internal Medicine · 2005 · 63 citations

Medicine, Veterinary Oncology, Veterinary Pharmacology +16

Hematological Toxicity and Therapeutic Efficacy of Lomustine in 20 Tumor-Bearing Cats: Critical Assessment of a Practical Dosing Regimen

Timothy M. Fan, Barbara E. Kitchell, Ravinder S. Dhaliwal et al. · Journal of the American Animal Hospital Association · 2002 · 46 citations

Medicine, Oncology, Pharmacology +17